RegCell is a biotechnology company developing first-in-class therapies for autoimmune diseases and transplantation using its epigenetic reprogramming platform that leverages the natural biology of regulatory T-cells (Tregs)
RegCell is a biotechnology company developing first-in-class therapies for autoimmune diseases and transplantation using its epigenetic reprogramming platform that leverages the natural biology of regulatory T-cells (Tregs).